These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8493359)

  • 21. Misoprostol: an effective agent for cervical ripening and labor induction.
    Wing DA; Rahall A; Jones MM; Goodwin TM; Paul RH
    Am J Obstet Gynecol; 1995 Jun; 172(6):1811-6. PubMed ID: 7778637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of collagenases and proteases in prostaglandin-induced cervical ripening.
    Rath W; Adelmann-Grill BC; Pieper U; Kuhn W
    Prostaglandins; 1987 Jul; 34(1):119-27. PubMed ID: 2825246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical and biomechanical characteristics of rat cervical ripening are not consistent with increased collagenase activity.
    Buhimschi IA; Dussably L; Buhimschi CS; Ahmed A; Weiner CP
    Am J Obstet Gynecol; 2004 Nov; 191(5):1695-704. PubMed ID: 15547544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
    Borten M; DiLeo LA; Friedman EA
    Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The physiology of cervical ripening and cervical dilatation and the effect of abortifacient drugs.
    Uldbjerg N; Ulmsten U
    Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):263-82. PubMed ID: 2225599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2-induced ripening of the human cervix involves changes in proteoglycan metabolism.
    Norman M; Ekman G; Malmström A
    Obstet Gynecol; 1993 Dec; 82(6):1013-20. PubMed ID: 8233252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The use of prostaglandin E2 to induce labor and abortion in the second trimester].
    Khadzhiev A
    Akush Ginekol (Sofiia); 1991; 30(1):39-45. PubMed ID: 1793135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of antiprogestin (RU 486) for termination of second trimester pregnancy.
    Gottlieb C; Bygdeman M
    Acta Obstet Gynecol Scand; 1991; 70(3):199-203. PubMed ID: 1927296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulprostone for preoperative cervical dilatation in primigravidae scheduled for late first trimester termination of pregnancy.
    Jerve F; Fylling P
    Arch Gynecol; 1983; 233(3):199-203. PubMed ID: 6625666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Labor characteristics of uncomplicated prolonged pregnancies after induction with intracervical prostaglandin E2 gel versus intravenous oxytocin.
    Papageorgiou I; Tsionou C; Minaretzis D; Michalas S; Aravantinos D
    Gynecol Obstet Invest; 1992; 34(2):92-6. PubMed ID: 1398272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in collagen content of the first trimester cervix uteri after treatment with prostaglandin F2 alpha gel.
    Rath W; Theobald P; Kühnle H; Kuhn W; Hilgers H; Weber L
    Arch Gynecol; 1982; 231(2):107-10. PubMed ID: 7073332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biochemical principles of cervix ripening and dilatation].
    Rath W; Osmers R; Stuhlsatz HW; Adelmann-Grill BC
    Z Geburtshilfe Perinatol; 1994; 198(5-6):186-95. PubMed ID: 7717006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Principles of physiologic and drug-induced cervix ripening--recent morphologic and biochemical findings].
    Rath W; Osmers R; Adelmann-Grill BC; Stuhlsatz HW; Tschesche H; Szevérini M
    Geburtshilfe Frauenheilkd; 1990 Sep; 50(9):657-64. PubMed ID: 2272430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collagen degradation in the pregnant human cervix at term and after prostaglandin-induced cervical ripening.
    Rath W; Adelmann-Grill BC; Pieper U; Kuhn W
    Arch Gynecol; 1987; 240(3):177-84. PubMed ID: 3036024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ripening of the cervix by intracervical application of PGE2-gel before termination of pregnancy with dilatation and evacuation.
    Wingerup L; Ulmsten U; Andersson KE
    Acta Obstet Gynecol Scand Suppl; 1979; 84():15-8. PubMed ID: 377896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new prostaglandin E2-gel for pretreatment of the cervix in nulliparous patients having a late first trimester termination of pregnancy.
    Wingerup L; Ulmsten U; Bygdeman M; Ekman G; Hamberger L; Lundström V; Norström A
    Arch Gynecol; 1981; 231(1):1-6. PubMed ID: 6949498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ripening of the cervix uteri at term by a single intracervical application of prostaglandin E2 gel].
    Cabrol D; Bernard N; Chouraqui A; Domenichini Y; Lemaire P; Lopes P; Morelli E; Reme JM; Treisser A; Uzan S
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(4):527-34. PubMed ID: 3209832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experiences with a new gel for intracervical application of prostaglandin E2 before therapeutic abortion or induction of term labor.
    Ulmsten U; Wingerup L
    Prostaglandins; 1980 Sep; 20(3):533-46. PubMed ID: 6999546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment of the cervix with 9-deoxy-16,16-dimethyl-9-methylene-prostaglandin E2 (Meteneprost) vaginal pessaries before first trimester legal abortion in nulliparae.
    Nyholm HC; Mikkelsen AL; Secher NJ
    J Obstet Gynaecol (Lahore); 1988; 8(3):210-3. PubMed ID: 12342310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.